High Net Worth Advisory Group’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,000
| Closed | -$44.6K | – | 259 |
|
|
2022
Q4 | $44.6K | Hold |
1,000
| – | – | 0.02% | 345 |
|
|
2022
Q3 | $28K | Sell |
1,000
-1,000
| -50% | -$28K | 0.01% | 410 |
|
|
2022
Q2 | $54K | Hold |
2,000
| – | – | 0.02% | 308 |
|
|
2022
Q1 | $68K | Hold |
2,000
| – | – | 0.02% | 299 |
|
|
2021
Q4 | $77K | Buy |
+2,000
| New | +$77K | 0.03% | 292 |
|